These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19126645)

  • 1. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
    Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
    Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
    Maeda T; Desouky J; Friedl A
    Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretion.
    Schneider C; Kässens N; Greve B; Hassan H; Schüring AN; Starzinski-Powitz A; Kiesel L; Seidler DG; Götte M
    Fertil Steril; 2013 Mar; 99(3):871-881.e1. PubMed ID: 23206733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
    Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
    Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
    Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
    Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
    Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
    Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
    Oh JH; Kim JH; Ahn HJ; Yoon JH; Yoo SC; Choi DS; Lee IS; Ryu HS; Min CK
    Gynecol Oncol; 2009 Sep; 114(3):509-15. PubMed ID: 19539355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
    Belguise K; Kersual N; Galtier F; Chalbos D
    Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation.
    Collier ME; Li C; Ettelaie C
    Mol Cancer Res; 2008 Dec; 6(12):1807-18. PubMed ID: 19074826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of metalloproteinases-1 stimulates gene expression in MDA-MB-435 human breast cancer cells by means of its ability to inhibit metalloproteinases.
    Porter JF; Sharma S; Wilson DL; Kappil MA; Hart RP; Denhardt DT
    Breast Cancer Res Treat; 2005 Nov; 94(2):185-93. PubMed ID: 16142437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway.
    Shen X; Qian L; Falzon M
    Exp Cell Res; 2004 Apr; 294(2):420-33. PubMed ID: 15023531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness.
    Hsu YM; Chou CY; Chen HH; Lee WY; Chen YF; Lin PW; Alper SL; Ellory JC; Shen MR
    J Cell Physiol; 2007 Mar; 210(3):626-36. PubMed ID: 17133354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
    Ribeiro AS; Albergaria A; Sousa B; Correia AL; Bracke M; Seruca R; Schmitt FC; Paredes J
    Oncogene; 2010 Jan; 29(3):392-402. PubMed ID: 19901964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
    Sizemore S; Cicek M; Sizemore N; Ng KP; Casey G
    Cancer Res; 2007 Jul; 67(13):6183-91. PubMed ID: 17616675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
    Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.